Brief: Heidelberg Pharma Adjusts 2021 Guidance

Heidelberg Pharma AG

01/10/2021 12:52

Oct 1 (Reuters) - HEIDELBERG PHARMA AG  HPHA.DE :
    * ANNOUNCES ADJUSTMENT OF GUIDANCE
    * EXPECTS FOR FINANCIAL YEAR 2021 SALES AND OTHER INCOME
BETWEEN
EUR 2.0 MILLION AND EUR 2.5 MILLION (PREVIOUSLY: EUR 5.5 MILLION
TO EUR 7.5 MILLION)
    * OPERATING EXPENSES WILL RANGE BETWEEN EUR 26.0 MILLION AND
EUR
28.5 MILLION (PREVIOUSLY: EUR 36.0 MILLION TO EUR 40.0 MILLION)
IN 2021
    * OUTLOOK 2021: (EBIT) BETWEEN EUR -23.5 MILLION AND EUR
-26.5
MILLION IS EXPECTED (PREVIOUSLY: EUR -30.0 MILLION TO EUR -34.0
MILLION)

Source text for Eikon:  ID:nEQ5JS4Mca 
Further company coverage:  HPHA.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))